Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis

Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a chronic progressive fibrotic interstitial pneumonia with unknown causes. The incidence rate increases year by year and the prognosis is poor without cure. Recently, phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB/AKT) signaling pathway can be consi...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs: Jincheng Wang, Kaili Hu, Xuanyan Cai, Bo Yang, Qiaojun He, Jiajia Wang, Qinjie Weng
Formaat: Artikel
Taal:English
Gepubliceerd in: Elsevier 2022-01-01
Reeks:Acta Pharmaceutica Sinica B
Onderwerpen:
Idiopathic pulmonary fibrosis
PI3K/AKT signaling
Pathogenesis
Coagulation cascade
Immune activation
Fibroblast accumulation
Online toegang:http://www.sciencedirect.com/science/article/pii/S2211383521002719

Internet

http://www.sciencedirect.com/science/article/pii/S2211383521002719

Gelijkaardige items